IMO ACT has caused the PPS and volume that we have here today. And,
watch that volume. This should be trading an average of 30-50mil
shares per day with the float of 2 billion shares. 5-10mil just
doesn't get it.
It's not what anyone's posting on any board that has caused ACT to
deteriorate. They have done it to themselves.
Those cells better work as hyped by this group of public company
BOD's and officers.
IMO, this company should have stayed private until some revenue
started to come in (IF). But, they elected long ago, because no
private investor's would touch this company to use the OTC to
dilute dilute dilute like every other OTC company does.
Lincoln Park, Camofi, and the others get or have got shares which
have been or will be dumped on the market and dilute the share
price again. Read the Q10-3 or Q10-4 when it comes out read good
Sir.
"We continue to repay our debt financing's in shares of common stock, enabling us to use our cash resources to fund our operations."
"We have no therapeutic products currently available for sale and do not expect to have any therapeutic products commercially available for sale for a period of years, if at all. These factors indicate that our ability to continue research and development activities is dependent upon the ability of management to obtain additional financing as required."
"We expect that research and development expenses will increase in the foreseeable future as we add personnel, expand our pre-clinical research, continue clinical trial activities, and increase our regulatory compliance capabilities."
News 
Market Data 
Discover 
AI
